Ordering Recommendation
Monitor treatment efficacy of low molecular weight heparin.
Mnemonic
Methodology
Chromogenic Assay
Performed
Sun-Sat
Reported
1-2 days
New York DOH Approval Status
Specimen Required
Lt. blue (sodium citrate). Refer to Specimen Handling at aruplab.com for hemostasis/thrombosis specimen handling guidelines.
Centrifuge specimen within one hour of collection. Transport 2 mL platelet-poor plasma. (Min: 1.5 mL)
Frozen.
Serum. EDTA, oxalate, heparin, or plasma separator tubes. Specimens refrigerated more than eight hours. Hemolyzed specimens.
This test cannot be used to quantitate anticoagulants other than low molecular weight heparin. This includes, but is not limited to, direct oral anticoagulants and Fondaparinux (Arixtra).
After separation from cells: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 1 month
University of Utah Clients: After separation from cells: Ambient: 4 hours; Refrigerated: 8 hours; Frozen: 2 weeks
Reference Interval
0.50-1.10 U/mL
Interpretive Data
Therapeutic range based on enoxaparin brand low molecular weight heparin.
FDA
Note
Hotline History
Hotline History
CPT Codes
85520
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0030144 | Heparin Anti-Xa Lmwh | 3274-8 |
Aliases
- Anti-10a
- Anti-Xa
- Heparin Anti-Xa Assay
- Heparin Anti-Xa Assay, Plasma
- Low-Molecular Weight Heparin Assay